Fluorescent diagnostic probes in neurodegenerative diseases
Neurodegenerative diseases are debilitating disorders that feature progressive and
selective loss of function or structure of anatomically or physiologically associated neuronal …
selective loss of function or structure of anatomically or physiologically associated neuronal …
The role of vitamin C in stress-related disorders
B Moritz, AE Schmitz, ALS Rodrigues, AL Dafre… - The Journal of …, 2020 - Elsevier
Stress-related disorders, such as depression and anxiety, present marked deficits in
behavioral and cognitive functions related to reward. These are highly prevalent disabling …
behavioral and cognitive functions related to reward. These are highly prevalent disabling …
Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress
M Moretti, A Colla, G de Oliveira Balen… - Journal of psychiatric …, 2012 - Elsevier
Reactive oxygen species (ROS) have been shown to play a role in the pathophysiology of
depression. Taking into account that experimental chronic unpredictable stress (CUS) …
depression. Taking into account that experimental chronic unpredictable stress (CUS) …
Phytochemical constituents as future antidepressants: a comprehensive review
R Bahramsoltani, MH Farzaei, MS Farahani… - Reviews in the …, 2015 - degruyter.com
Depression is a major mental disease that is ranked as the fourth leading cause of disability.
In order to avoid unwanted adverse reactions, as well as improve efficacy, current …
In order to avoid unwanted adverse reactions, as well as improve efficacy, current …
Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases
M Moretti, DB Fraga… - CNS neuroscience & …, 2017 - Wiley Online Library
In this review, we summarize the involvement of ascorbic acid in neurodegenerative
diseases by presenting available evidence on the behavioral and biochemical effects of this …
diseases by presenting available evidence on the behavioral and biochemical effects of this …
Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways
I Holzmann, LM da Silva, JAC da Silva… - Pharmacology …, 2015 - Elsevier
Olfactory bulbectomy (OB) is an animal model of depression that can mimic symptoms that
are characteristic of depressive patients, such as behavioral, neurochemical and …
are characteristic of depressive patients, such as behavioral, neurochemical and …
[PDF][PDF] Effects of oral vitamin C supplementation on anxiety in students: a doubleblind, randomized, placebo-controlled trial
C Ribeiro - Pakistan journal of biological sciences, 2015 - researchgate.net
Vitamin C (ascorbic acid) is a well-known antioxidant that is involved in anxiety, stress,
depression, fatigue and mood state in humans. Studies have suggested that oxidative stress …
depression, fatigue and mood state in humans. Studies have suggested that oxidative stress …
Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice
Studies have demonstrated an association between stressful conditions and the onset of
clinical depression. Considering the antidepressant-like properties of ascorbic acid in both …
clinical depression. Considering the antidepressant-like properties of ascorbic acid in both …
Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors
Background It has been suggested that dysregulation of γ-aminobutyric acid (GABA)-
mediated neurotransmission is involved in the etiology of major depressive disorder and in …
mediated neurotransmission is involved in the etiology of major depressive disorder and in …
Anxiolytic effects of ascorbic acid and ketamine in mice
Some studies have demonstrated that ascorbic acid, similarly to ketamine, exhibits
antidepressant-like effects mediated, at least in part, by modulation of the glutamatergic …
antidepressant-like effects mediated, at least in part, by modulation of the glutamatergic …